Tongue Pain and Giant Cell Arteritis SIR, p. 337 ) draws attention to the importance of pain in the tongue as a feature in giant cell arteritis. We have found glossitis in 12.6% of a series of 87 cases of temporal arteritis.' ' The glossitis varied from gangrene of the anterior two-thirds of the tongue to a sensation of burning. Commonly the tongue was raw-beef red and sore. There were also examples of blistering and bruising, and this, together with the pathogenesis of other skin lesions in giant cell arteritis, has led us to suppose that in vascular areas such as the tongue, scalp, and face necrosis is due to haemorrhage rather than occlusion. ' We agree with Dr. Derm. 1965, 77, 193. Dhermat. Digest, 1966, 5, No. 8, 5 1.
Brit. 7. Derm., 1964, 76, 299. Cross-infection in a Surgical Unit SIR,-Dr. J. E. Tinne and others (11 November, p. 313) acknowledge that the addition of colistin to the routine post, operative drip may be essential in combating the type of infection reported. They do, however, caution, ". . . its nephrotoxicity must be borne in mind."
To date no positive histopathological evidence has been offered to support the claim that colistin Is nephrotoxic. The evidence from animal studies' is that when massive doses (19.2 mg./ kg./day intraperitoneally) are given to rats and mice only very slight congestion with tubular necrosis can be detected; at levels of 9.6 mg./ kg./day no such changes are seen. For such effects to appear in man, therefore, a dose of about 1,152 mg./day would be required, which is some 41 times the recommended dose. In humans no histological evidence of damage was found in 11 renal biopsies2 3 following therapeutic doses of colistin, although Katz,4 using an excessive dose (15.4 mg./kg./day), believed that in one patient nephrotoxicity was apparent, but the findings suggest that the lesion was regressing.
The question of nephrotoxicity must therefore be discussed in the light of reports of elevated blood urea nitrogen and plasma creatinine levels in patients receiving colistin for urinary infections' or in healthy volunteers.' A fall in blood urea nitrogen during therapy has also been found,8 and the effect on renal function is clearly dose-dependent. 9 Even so, doses of up to 720 mg./day have been used without affecting blood urea nitrogen,'" and in conditions of elevated levels prior to therapy (>50 mg./100 ml.) no further change has been attributable to colistin.1' The reason for these variable transient and reversible changes in blood urea and creatinine in some cases is not clear. It has been suggested' that colistin may be vasoactive, reducing renal blood flow and glomerular filtration rate, although this has been challenged4 on the basis of one case.
Clearly, so far as we are aware, no irreversible damage to the kidney has been demonstrated, and, whatever the significance of the observed blood changes, it is still held' ' that the administration of colistin is of such therapeutic benefit as to allow its controlled use even where renal dysfunction is proved. As has rightly been pointed out by Dr. practitioners, although deriving benefit from their hearing-aids in their private lives, are prevented from using them in their professional work because of the difficulties involved in the concurrent use of an aid and the traditional binaural stethoscope. So long as the hearing-aid has a microphone cut-out switch, however, there is no reason why a transistorized stethoscope should not be used with the ear-insert in situ. The essential components of a home-made (or doit-yourself) transistorized stethoscope may be found in any hearing-aid repair department. The minor modifications in wiring of the components are well within the scope of anyone with a minimum of electronic know-how and take only a few minutes. The photograph illustrates the compactness of the gadget and the ease with which it is used. Almost its only disadvantage is that it is a two-handed instrument; when used with a sphygmomanometer the chest-piece has to be tucked under the cuff or else held in position by the patient. I shall be pleased to supply details of the electrical modifications to anyone interested. Our patient was a boy aged 13. He was small and obese, and had not attained puberty.
When admitted to hospital (30 September 1967) he gave a history of dyspnoea, cough, and expectoration of about three weeks' duration. At first his sputum had been mucoid, but later it became purulent and was finally blood-stained. He had also suffered from nausea, retching, upper abdominal discomfort, and diarrhoea. On examination there was moderate overfilling of the jugular veins and the liver was enlarged about 2 cm. There were crepitations throughout the lung fields. The heart rate was 140 per minute, and the pulse was thready in character; the blood pressure was 95/60 mm. Hg.
The apex beat was heaving and was 2 cm. to the left of the mid-clavicular line in the fifth left intercostal space. Radiological examination revealed moderate generalized cardiac enlargement, and suggested the presence of a small pericardial effusion. The electrocardiogram showed a general low voltage pattern.
Digoxin, frusemide, and tetracycline were given. At first there was some reduction of dyspnoea, but the heart rate was unaffected, and nausea and retching persisted. Four weeks after admission he developed a pleural effusion and soon after this he died suddenly. Necropsy confirmed the diagnosis of myocarditis and the presence of a pulmonary embolus. These findings were considered to provide an adequate explanation of the patient's sudden death.
During the illness specimens of serum had been sent to the Regional Virus Laboratory, Ruchill Hospital, Glasgow. The only abnormal finding was the presence of anti-
